The “solution” is to give the jab to younger and younger ages
Explained: Pfizer seeks NZ approval for BA.5-targeted vax MedSafe has also received an application for provisional approval of Pfizer’s earlier bivalent vaccine, targeted at the original Omicron type BA.1. Photo: Sebastian Gollnow / DPA / dpa Picture-Alliance via AFP MedSafe today received an application from Pfizer for provisional approval of its latest Omicron-targeted vaccine. What does it do and when will it be available? What’s the new vaccine? It’s called a bivalent vaccine, designed to protect against the coronavirus as we first…
